Vascular risk profile and changes of arterial hypertension after surgical revascularization in adult Moyamoya patients

Sci Rep. 2024 May 29;14(1):12364. doi: 10.1038/s41598-024-61966-8.

Abstract

Moyamoya disease (MMD) is a rare stenoocclusive cerebral vasculopathy often treated by neurosurgical revascularization using extracranial-intracranial bypasses to prevent ischemic or hemorrhagic events. Little is known about the vascular risk profile of adult MMD patients compared to the general population. We therefore analyzed 133 adult MMD patients and compared them with data from more than 22,000 patients from the German Health Update database. Patients with MMD showed an age- and sex-adjusted increased prevalence of arterial hypertension, especially in women between 30 and 44 years and in patients of both sexes between 45 and 64 years. Diabetes mellitus was diagnosed significantly more frequently in MMD patients with increasing age, whereas the vascular risk profile in terms of obesity, nicotine and alcohol consumption was similar to that of the general population. Antihypertensive medication was changed one year after surgical revascularization in 67.5% of patients with a tendency towards dose reduction in 43.2% of all patients. After revascularization, physicians need to be aware of a high likelihood of changes in arterial hypertension and should adjust all other modifiable systemic vascular risk factors to achieve the best treatment possible.

Keywords: Arterial hypertension; Cerebral revascularization; Moyamoya.

MeSH terms

  • Adult
  • Aged
  • Antihypertensive Agents / therapeutic use
  • Cerebral Revascularization* / adverse effects
  • Cerebral Revascularization* / methods
  • Female
  • Germany / epidemiology
  • Humans
  • Hypertension* / complications
  • Hypertension* / epidemiology
  • Male
  • Middle Aged
  • Moyamoya Disease* / surgery
  • Prevalence
  • Risk Factors
  • Young Adult

Substances

  • Antihypertensive Agents